Clinical updates, including trial initiations, enrollment status and data readouts and publications: Antibe, Ashvattha, Cardiol, Clearside, Curocell, Curevac, Cymabay, Dare, Evaxion, Innovative Cellular, Kazia, Merck & Co., Monopar, Silence, Soterios, Springworks, Tonix.